Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Mologic
Mologic
Activities:
Analysis
Pharmaceutical
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Overcoming CMC challenges in cell and gene therapy: part I
Certara’s Dr Hien Anh Bruno, Associate Director, Chemistry, Manufacturing and Controls (CMC), and Dr Deven Shah, CMC Lead, propose mitigation strategies to address the CMC...
Resolving capping issues in tablet manufacturing
Natoli explores the various causes of capping and the methods to prevent it
Effective ways to optimise heat exchangers
Heat exchangers are used within a wide range of process industries as a way to transfer heat between two fluid streams across a medium in an energy conservative way
Transforming healthcare with patient centricity
In this opinion article, John Kytariolos, Head of Clinical and Scientific Affairs at Adragos Pharma, discusses patient-centric dosage forms, their properties and the impact...
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Regulatory
Mologic’s COVID-19 self-test selected for RADx initiative funding
The initiative was launched by the US National Institutes of Health to accelerate the development, commercialisation and implementation of technologies for COVID-19 testing
Finance
Avacta and Mologic announce commercial partnership
Clinical evaluation of the lateral flow test is currently being carried out at a hospital in mainland Europe and Avacta will shortly initiate further clinical validation studies in the UK and abroad
Research & Development
Mologic launches rapid diagnostic test for fungal crop pathogen Botrytis
The company developed and trialled BotrytisAlert with Berry Garden Growers, NIAB EMR and the Warwickshire College
Research & Development
Mologic completes new ultra-sensitive rapid diagnostic test
The next phase of development will include setting up local manufacturing facilities in areas with need of the device for preventing the spread of epidemics
Pharmaceutical
Mologic expands US and UK operations
The UK-based company that develops lateral flow and rapid diagnostic technologies has made multiple appointments in order to bolster US presence
Subscribe now